Showing results (11-20 of 210) with videos related to
Sort By:
Pageof 21
BMC Pregnancy and Childbirth|September 4, 2019
Treatment resistant depression in women with peripartum depressionM Soledad Cepeda, David M Kern, Susan NicholsonTherapeutic Innovation & Regulatory Science|November 9, 2020
Identifying Anticipated Events of Future Clinical Trials by Leveraging Data from the Placebo Arms of Completed TrialsXiang-Lin Tan, David M Kern, M Soledad CepedaPain Medicine (Malden, Mass.)|October 27, 2020
Oral Opioid Prescribing Trends in the United States, 2002-2018David M Kern, M Soledad Cepeda, Anthony G SenaDepression and Anxiety|January 21, 2021
At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based studyM Soledad Cepeda, David M Kern, Carla M CanusoBMC Psychiatry|January 5, 2020
Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019David M Kern, M Soledad Cepeda, Frank Defalco, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2019
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medicationsDavid M Kern, M Soledad Cepeda, Simon Lovestone, et al.Epilepsia Open|August 8, 2022
Differences between men and women in response to antiseizure medication use and the likelihood of developing treatment resistant epilepsyM Soledad Cepeda, Rachel E Teneralli, David M Kern, et al.Clinical Drug Investigation|July 22, 2019
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug DiscoveryM Soledad Cepeda, David M Kern, Guy R Seabrook, et al.Journal of Clinical Lipidology|July 6, 2020
Low levels of cholesterol and the cholesterol type are not associated with depression: Results of a cross-sectional NHANES studyM Soledad Cepeda, David M Kern, Clair Blacketer, et al.CNS Drugs|February 4, 2021
Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor AntagonistsDavid M Kern, M Soledad Cepeda, Christopher M Flores, et al.Pageof 21